Partial Dopamine Agonists and Dopaminergic Stabilizers, in the Treatment of Psychosis

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 1, Iss. 2, 2002-04 ,pp. : 141-147

Bentham Science Publishers

Access to resources Recommend Favorite

Receptor-Binding and Pharmacokinetic Properties of Dopaminergic Agonists

By  

Current Topics in Medicinal Chemistry, Vol. 8, Iss. 12, 2008-08 ,pp. : 1049-1067

Bentham Science Publishers

Access to resources Recommend Favorite

Design, synthesis, and a novel application of quorum-sensing agonists as potential drug-delivery vehicles

By Ganguly Kumkum   Wu Ruilian   Ollivault-Shiflett Morgane   Goodwin Peter M.   Silks Louis A.   Iyer Rashi  

Journal of Drug Targeting, Vol. 19, Iss. 7, 2011-08 ,pp. : 528-539

Informa Healthcare

Access to resources Recommend Favorite

Design and Synthesis of Novel 1,3-Dioxane-2-carboxylic Acid Derivatives as PPARα/γ Dual Agonists

By  

Letters in Drug Design & Discovery, Vol. 7, Iss. 6, 2010-07 ,pp. : 421-429

Bentham Science Publishers

Access to resources Recommend Favorite

Design, Synthesis and Evaluation of Peroxisome Proliferator-Activated Receptor /&bgr;Dual Agonists for the Treatment of Type 2 Diabetes

By  

Letters in Drug Design & Discovery, Vol. 4, Iss. 1, 2007-01 ,pp. : 27-32

Bentham Science Publishers

Access to resources Recommend Favorite